Topic:
Partnering
Latest Headlines
Latest Headlines
Roche, Cook help launch public-private Indiana research institute
Indiana devicemakers are among a throng of biotech industry players that has taken up with the state to launch an estimated $360 million public-private research institute to further Indiana's already-thriving biotech industry.
Sequenom reaches into France with prenatal Dx
Sequenom has inked a deal with France's Laboratoire Cerba to expand the reach of the company's MaterniT21 Plus test, designed to non-invasively detect chromosomal abnormalities.
UCLA slams the door on GlaxoSmithKline's latest R&D competition
GlaxoSmithKline's latest attempt to enlist the academic community in its translational research efforts has won a chilly reception from the upper echelon of UCLA.
Pfizer taps UCSF for small-molecule drug discovery
In an effort to widen its search for new small-molecule drug candidates, Pfizer is extending its biologics partnership with the University of California, building on the company's already robust Centers for Therapeutic Innovation program.
Cempra wins $58M BARDA contract for lead antibiotic
Chapel Hill, NC-based Cempra has won a $58 million contract from BARDA to develop its lead, late-stage antibiotic for bioterror threats aimed at a pediatric population.
Illumina taps Hamilton Robotics for sequencing automation
Illumina has partnered with Hamilton Robotics to develop automated sample preparation for the company's next-generation sequencing platforms.
Sights set on Asia, Amgen sets up JV development deal with Astellas
Just a few months after Amgen execs lamented a big Asian gap in their global strategy, the Big Biotech company has joined hands with Astellas to set up a new joint venture in Japan. Amgen is contributing 5 experimental-stage programs to the JV, including their late-stage anti-PCSK9 program for the cholesterol drug AMG-145.
Luminex re-ups assay deal with Merck KGaA
Luminex has inked a long-term agreement with Merck KGaA's life sciences business, tasking the German company with providing assays for Luminex's research technology.
CRO Cenix signs on with Debiopharm for cancer R&D
German CRO Cenix BioScience has agreed to handle preclinical work for Debiopharm's oncology pipeline, using its high-content assays to identify biomarkers.
Corgenix inks cancer deal with Lilly
Diagnostics outfit Corgenix has paired up with Eli Lilly to develop tests for the drugmaker's oncology pipeline, a step forward in the company's efforts to expand its contract services business.
